Endoscopic Ultrasound Needles Market Segmentation:
Product Type Segment Analysis
The fine needle aspiration (FNA) needles segment is poised to hold the dominant share of 42.7% in the market by the end of 2035. The leadership is primarily attributable to the increasing use of this subtype in malignancy screening, with the rising incidence and complexity of cancer. Such large-scale utilization can be justified by the high diagnostic performance of these needles in cancer detection. As evidence, in June 2025, the NLM published an experimental study that evaluated the performance of endoscopic ultrasound-guided fine-needle aspiration for splenic lesions. It established this type of needle to be a highly accurate and safe diagnostic tool, delivering 100% in diagnostic accuracy, sensitivity, and specificity.
Application Segment Analysis
Oncology diagnostics is expected to account for 38.5% revenue share in the market over the assessed period. The critical role of these tools in cancer detection and staging is the foundational pillar of this forefront position. Thus, the magnifying volume of the patient pool of malignancies is directly benefiting this sector. With EUS-guided biopsies becoming a standard approach for evaluating tumors in hard-to-reach areas such as the pancreas and lungs, the segment is becoming the primary source of cash inflow in this field. Moreover, payer-driven support, notably insurance coverage expansion for EUS-based cancer staging, is increasing procedural volumes and encouraging wider clinical adoption.
End user Segment Analysis
Hospitals are estimated to dominate the end-user segment by capturing a 55.3% share in the market throughout the analyzed timeframe. The factor that solidifies their position is the widened access to advanced imaging infrastructure, skilled specialists, and comprehensive diagnostic and therapeutic capabilities. EUS procedures, particularly for cancer diagnosis and staging, are increasingly integrated into hospital workflows due to their complexity and the need for multidisciplinary care. Such a captivity over the large consumer base is further complemented by favorable reimbursement policies and institutional procurement initiatives, which enable them to adopt high-quality EUS needle technologies at scale.
Our in-depth analysis of the global market includes the following segments:
|
Segment |
Subsegments |
|
Product Type |
|
|
Application |
|
|
End user |
|
|
Needle Size |
|
|
Usability |
|
